About us Editorial board Search Ahead of print Current issue Archives Instructions Subscribe Contacts Login 
Home Print this page Email this page Users Online: 247
Year : 2021  |  Volume : 8  |  Issue : 2  |  Page : 39-43

Optical coherence tomography biomarkers in diabetic macular edema

1 Imaging Unit - iCare Eye Hospital, Alexandria, Egypt
2 Department of Opthalmology, Alexandria Faculty of Medicine, Cairo, Egypt; Joslin Diabetes Center, Beetham Eye Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA
3 Department of Opthalmology, Alexandria Faculty of Medicine, Cairo, Egypt
4 Department of Ophthalmology, Kasr Al Ainy School of Medicine, Cairo, Egypt

Correspondence Address:
Dr. Amira Mohamed Mostafa
iCare Eye Hospital, Somed Building #3 - El Mahmoudeya Axis – Smouha, P. O. 21648, Alexandria
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/erj.erj_3_22

Rights and Permissions

Biomarkers are defined as measurable objective indicators that can be used to assess normal physiological process, pathological process and/or tissue response to pharmacological therapeutic agents. In this review article, we address the most notable structural changes encountered in DME patients and their impact on treatment planning and outcomes.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded294    
    Comments [Add]    

Recommend this journal